Environmental Risk Assessment (ERA) is a mandatory requirement for EMA submissions and global regulatory approvals. Companies often struggle to coordinate regulatory strategy, PEC calculations, Phase II testing, and PBT assessment across multiple partners.

We offer a true one-stop solution, combining regulatory ERA consulting with in-house ecotoxicology, biodegradability, and analytical testing capabilities. 

Integrated ERA testing & consulting

Expand_img

Coordinated management of environmental studies, analytical support, ecotoxicology testing, and regulatory documentation within a single framework.

Tailored testing strategy

Expand_img

Definition of a risk-based ERA testing strategy integrating Phase I screening, Phase II study planning, and alignment with EMA guidelines. Testing activities can be directly coordinated within the Eurofins laboratory network.

Gap analysis

Expand_img

Comprehensive review of available environmental data to identify missing endpoints, optimise testing requirements, and reduce unnecessary studies through scientifically justified waivers.

PBT/vPvB assessment

Expand_img

Regulatory evaluation of PBT and very Persistent, very Bioaccumulative (vPvB) criteria supported by laboratory data and scientific interpretation.

Regulatory Communication & Data Access Strategy

Expand_img

We support companies in liaising with competent authorities, managing communications on their behalf, also assisting in obtaining Letters of Access (LoA) from original Marketing Authorisation Holder (MAH), when applicable.